Suppression of EAE and prevention of blood-brain barrier breakdown after vaccination with novel bifunctional peptide inhibitor
about
Suppression of MOG- and PLP-induced experimental autoimmune encephalomyelitis using a novel multivalent bifunctional peptide inhibitor.Peptides and peptidomimetics as immunomodulators.Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitisImmune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal.I-domain-antigen conjugate (IDAC) for delivering antigenic peptides to APC: synthesis, characterization, and in vivo EAE suppressionBifunctional Peptide Inhibitors Suppress Interleukin-6 Proliferation and Ameliorates Murine Collagen-Induced ArthritisVaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): targeting multiple antigenic peptides to APCInhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitisControlling immune response and demyelination using highly potent bifunctional peptide inhibitors in the suppression of experimental autoimmune encephalomyelitis.Synthesis of a Bifunctional Peptide Inhibitor-IgG1 Fc Fusion That Suppresses Experimental Autoimmune Encephalomyelitis.Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice.Deficient Arginase II Expression without Alteration in Arginase I Expression Attenuated Experimental Autoimmune Encephalomyelitis in Mice.Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases.
P2860
Q34070020-04F8217A-009D-44F9-9479-2B2055857970Q34359984-587A6106-7C23-4063-9E95-9C9BABDD70FCQ35318380-AAACED85-20CB-4130-8D50-C900A2AF3446Q35571156-51A28F7F-800A-43C7-842B-0757D9AC921AQ35794350-89D7AE42-05CF-48D8-8982-76BB96EB22D8Q35848759-0E5F2256-0B1D-4E6E-8966-B3EF7AF53DD4Q35915683-A07A567D-9AC6-4A25-8CF8-619D426E9CB1Q36518182-65614BAD-9A85-4311-85E9-249E3C7ABC51Q37194323-A1F890DB-B76F-4BF0-9FE8-DE928FC24F94Q45806642-81047810-0BA3-4619-B271-1B43A2A34D84Q46299475-3A084DD8-CF8B-4D20-84AF-BE0A64159908Q48266450-CC3E70D4-E778-4786-899C-6BA90FBC37ABQ51735384-1B388E82-1195-4B6F-A89D-669FF6015BE2Q52708818-E5A49BCF-B4E0-4804-903C-C74E7A6AB9BB
P2860
Suppression of EAE and prevention of blood-brain barrier breakdown after vaccination with novel bifunctional peptide inhibitor
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Suppression of EAE and prevent ...... bifunctional peptide inhibitor
@ast
Suppression of EAE and prevent ...... bifunctional peptide inhibitor
@en
type
label
Suppression of EAE and prevent ...... bifunctional peptide inhibitor
@ast
Suppression of EAE and prevent ...... bifunctional peptide inhibitor
@en
prefLabel
Suppression of EAE and prevent ...... bifunctional peptide inhibitor
@ast
Suppression of EAE and prevent ...... bifunctional peptide inhibitor
@en
P2093
P2860
P1433
P1476
Suppression of EAE and prevent ...... bifunctional peptide inhibitor
@en
P2093
Ahmed H Badawi
Charlotte M Vines
In-Young Choi
Paul Kiptoo
Teruna J Siahaan
Wen-Tung Wang
P2860
P304
P356
10.1016/J.NEUROPHARM.2011.12.013
P50
P577
2011-12-17T00:00:00Z